The Ensign Group is a medical care facilities business based in the US. The Ensign Group shares (ENSG) are listed on the NASDAQ and all prices are listed in US Dollars. The Ensign Group employs 25,900 staff and has a trailing 12-month revenue of around $2.9 billion.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $92.40 |
|---|---|
| 52-week range | $70.15 - $99.52 |
| 50-day moving average | $93.95 |
| 200-day moving average | $85.24 |
| Wall St. target price | $106.60 |
| PE ratio | 24.9973 |
| Dividend yield | $0.22 (0.25%) |
| Earnings per share (TTM) | $3.76 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $92.4 from 2023-02-03
| 1 week (2023-01-27) | 1.12% |
|---|---|
| 1 month (2023-01-04) | -3.63% |
| 3 months (2022-11-04) | 1.27% |
| 6 months (2022-08-04) | 10.17% |
| 1 year (2022-02-02) | 24.33% |
|---|---|
| 2 years (2021-02-04) | 6.69% |
| 3 years (2020-02-04) | 97.65% |
| 5 years (2018-02-02) | 338.55% |
Valuing The Ensign Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Ensign Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Ensign Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, The Ensign Group shares trade at around 25x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
The Ensign Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.307. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Ensign Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Ensign Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $346.2 million.
The EBITDA is a measure of a The Ensign Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.9 billion |
|---|---|
| Operating margin TTM | 9.87% |
| Gross profit TTM | $482.3 million |
| Return on assets TTM | 5.91% |
| Return on equity TTM | 19.72% |
| Profit margin | 7.32% |
| Book value | $21.46 |
| Market capitalisation | $5.2 billion |
TTM: trailing 12 months
Dividend payout ratio: 7.32% of net profits
Recently The Ensign Group has paid out, on average, around 7.32% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.25% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Ensign Group shareholders could enjoy a 0.25% return on their shares, in the form of dividend payments. In The Ensign Group's case, that would currently equate to about $0.22 per share.
While The Ensign Group's payout ratio might seem low, this can signify that The Ensign Group is investing more in its future growth.
The Ensign Group's most recent dividend payout was on 30 January 2023. The latest dividend was paid out to all shareholders who bought their shares by 28 December 2022 (the "ex-dividend date").
The Ensign Group's shares were split on a 1069:1000 basis on 30 September 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1069 shares. This wouldn't directly have changed the overall worth of your The Ensign Group shares – just the quantity. However, indirectly, the new 6.5% lower share price could have impacted the market appetite for The Ensign Group shares which in turn could have impacted The Ensign Group's share price.
Over the last 12 months, The Ensign Group's shares have ranged in value from as little as $70.1468 up to $99.52. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while The Ensign Group's is 0.9836. This would suggest that The Ensign Group's shares are less volatile than average (for this exchange).
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of October 3, 2022, it operated 268 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.